Voicd Information

Voicd™ is a voice intelligence company. We measure the physiology that produces speech — not just how a recording sounds. Voices can now be cloned convincingly and cheaply. Voicd exists so that the question “is this really the person speaking?” has a defensible answer. Voicd measures the biological system that produces human speech and evaluates whether a recording is consistent with it. That measurement is a voice biomarker: a physiological signal, not an acoustic score, whose scientific foundation has been accepted in a United States federal court in the same evidentiary class as fingerprints and DNA. Synthetic speech is refused outright rather than assigned a confidence score, because the physiology it would need to carry is absent. The platform runs one architecture, three products and four analyzers. AI Live Voice works in real time on the call path. AI Forensic supports examiner-driven analysis of recorded audio with hash-anchored chain-of-custody. PACS Multimodal fuses voice with other credentials for physical access. The Lexicon layer handles language, transcription and meaning across 200+ languages, including code-switching. The methodology meets the Daubert standard and has been accepted as evidence in a United States federal court. Our research is grounded in a sponsored research relationship with the Carnegie Mellon University Center for Voice Intelligence and Security. We hold a European patent at Notice of Intention to Grant, active filings in the United States and China, and five provisional applications filed in June 2026. Voicd is delivered through our partnership with Ardian Group on infrastructure operating in a FISMA-compliant posture, with FIPS-validated cryptography and DISA STIG hardening. Deployment runs on managed cloud, on customer-owned hardware, or across both, including air-gapped environments. Voicd is a product of AIVA Global, Inc